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Notch2 complements Notch1 to mediate inductive
signaling that initiates early T cell development
Maile Romero-Wolf1, Boyoung Shin1, Wen Zhou1, Maria Koizumi2, Ellen V. Rothenberg1, and Hiroyuki Hosokawa1,2
Notch signaling is the dominant intercellular signaling input during the earliest stages of T cell development in the thymus.
Although Notch1 is known to be indispensable, we show that it does not mediate all Notch signaling in precommitment stages:
Notch2 initially works in parallel to promote early murine T cell development and antagonize other fates. Notch-regulated
target genes before and after T lineage commitment change dynamically, and we show that this partially reflects shifts in
genome-wide DNA binding by RBPJ, the transcription factor activated by complex formation with the Notch intracellular
domain. Although Notch signaling and transcription factor PU.1 can activate some common targets in precommitment
T progenitors, Notch signaling and PU.1 activity have functionally antagonistic effects on multiple targets, delineating
separation of pro-T cells from alternative PU.1-dependent fates. These results define a distinct mechanism of Notch signal
response that distinguishes the initial stages of murine T cell development.
Introduction
Notch signaling is the main inductive signal for development of
T lymphocytes in the thymus (Hozumi, 2020; Radtke et al.,
2013). The Notch pathway is evolutionarily conserved and reg-
ulates differentiation and organization in diverse organs and cell
types. Mammals have four Notch family members, Notch1–4,
and multiple Notch ligands of delta-like (DLL) and Jagged fam-
ilies. Notably, Notch acts both as a cell surface receptor and as a
transcriptional coactivator (Bray, 2006). Binding of cell surface
Notch by Notch ligands triggers proteolytic release of the in-
tracellular domain of Notch (ICN), which translocates to the
nucleus to become a coactivator for the DNA binding protein
RBPJ. In hematopoiesis, early T cell development in the thymus
is the best-studied system for the roles of Notch signaling
(Hozumi, 2020; Radtke et al., 2013). Conditional deletion of
Notch1 or Delta-like 4 (Dll4) profoundly blocks T cell development
and promotes aberrant generation of B cells in the thymus
(Hozumi et al., 2008; Radtke et al., 1999). Conversely, Notch
signaling driven by coculture with stromal cells expressing DLL
family Notch ligands (DLL1 or DLL4) induces T cell development
in vitro, and forced expression of ICN1 within fetal liver– or
bone marrow (BM)–derived non-T progenitor cells does so
in vivo (Hozumi et al., 2003; Pui et al., 1999; Schmitt and Zúñiga-
Pflücker, 2002).
T cell developmental stages in the thymus are defined by
markers such as CD4 and CD8. The immature cells are double-
negative (DN; CD4− CD8−) cells, which generate double-positive
(CD4+ CD8+) intermediate cells and then differentiate into ma-
ture CD4 and CD8 single-positive cells. DN thymocytes include
multiple substages distinguished by expression of CD44, Kit, and
CD25 (Hosokawa and Rothenberg, 2018; Yang et al., 2010; Yui
and Rothenberg, 2014). The earliest intrathymic precursors are
called “early T cell progenitor cells” (ETP; Kit2+CD44+CD25−) or
Kit+ DN1 cells (DN1a and DN1b; Porritt et al., 2004), and these
generate DN2a (Kit2+CD44+CD25+) stage pro-T cells. These stages
together comprise phase 1. Through days of proliferation, phase 1
cells in ETP and DN2a stages retain potential for non–T cell fates
and can switch to these alternative pathways if Notch signaling
is withdrawn. Then, at the transition of DN2a to DN2b
(Kitlower+CD44+CD25+) stages, pro-T cells become intrinsically
committed to the T lineage, entering phase 2. They then undergo
T cell receptor (TCR) gene rearrangement, with most TCRβ gene
rearrangement occurring at DN3a stage (Kit−CD44−CD25+CD28−).
Pre-TCR signaling next enables the cells to exit from the pro–T cell
stages and progress to later TCR-expressing stages. The require-
ment for Notch signaling extends from the earliest stages
throughout the commitment transition (Hirano et al., 2015;
Wolfer et al., 2002). Phase 1 stages (ETP and DN2a) are Notch-
dependent for T lineage fidelity and growth. Phase 2 (DN2b and
DN3a) stages are T lineage committed but are increasingly Notch
dependent for viability. Cells that pass beyond DN3a stage after
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pre-TCR signaling, or that differentiate to TCRγδ cells, finally be-
come Notch independent. Of note, Notch-dependent target genes
show different expression dynamics even within pro–T cell devel-
opment (Rothenberg et al., 2016), suggesting that stage-dependent
control mechanisms are at play.
It has been assumed that only Notch1 mediates inductive
signaling for T cell specification. In single-gene knockouts (KOs),
Notch1 disruption is sufficient to block T cell development,
whereas Notch3-deficient or Notch2-deficient mice develop normal-
seeming CD4 and CD8 populations under steady-state conditions in
the thymus (Saito et al., 2003; Shi et al., 2011; Suliman et al.,
2011). Several in vitro culture systems indicate that Notch2 could
play a supportive role for phase 1 pro-T stages (Besseyrias et al.,
2007; Hozumi et al., 2003), but this has been interpreted as an
artifact of using a Notch ligand in vitro that is less biased toward
Notch1 interaction than the DLL4 naturally used in the thymus. If
true, then it could be assumed that Notch1-deficient thymocytes
(Feyerabend et al., 2009) were completely lacking Notch signals.
However, Notch2 is highly expressed from hematopoietic stem
cells through phase 1, then decreases in phase 2. Furthermore,
although Notch3 is virtually absent in murine hematopoietic
stem cells and phase 1 cells, it is activated by Notch1 signaling in
the thymus and nicely expressed in phase 2. Thus, although
signaling from Notch2 and Notch3 is dispensable for T cell de-
velopment in vivo, these family members could have some
physiological roles, redundant or complementary with Notch1,
and might contribute to select stage-specific target gene regu-
lation in phase 1 and phase 2.
To resolve Notch family roles, we examined effects of acute
and stage-specific deletion of different Notch family member
genes, individually or in combination, in early T cell develop-
ment. The results show that Notch1 controls its target genes in
cooperation with Notch2, especially in phase 1. Notch-regulated
target genes are globally distinct in the two phases, and some of
these differences are linked with stage-specific shifts in RBPJ
binding across the genome. Although Notch1 appears to block B
lineage development from phase 1 cells, acute deletion of Notch2
along with Notch1 in phase 1 unleashes higher production of
myeloid cells as well. Gene expression profiles confirm specific
antagonisms between myeloid transcription factor, PU.1, and
Notch signaling in phase 1 pro-T cells. Thus, Notch signaling
drives T cell development not only by activating T lineage sig-
nature genes but also by repressing alternative lineage pro-
grams, including myeloid fate.
Results and discussion
Conditional deletion of Notch family genes inmice has shown an
indispensable role of Notch1 for the earliest T cell development
in vivo in the steady state. However, previous studies did not
exclude potential accelerating or modulating roles of Notch2 and
Notch3, which are also substantially expressed in phase 1 and
phase 2 pro-T cells, respectively (Yoshida et al., 2019; Fig. 1 A
and Fig. S1 A). Therefore, we compared single and double KOs
to test whether Notch2 or Notch3 contributed at all to Notch-
dependent function in early T cell development. Because avail-
able Cre mice do not delete specifically in phase 1, we exploited
in vitro T cell cultures (Holmes and Zúñiga-Pflücker, 2009) to
cause acute, stage-specific deletion of Notch family genes, singly
or in pairs, using a CRISPR/Cas9 system (Hosokawa et al., 2018;
Fig. 1 B). For deletions in phase 1, BM precursors from Cas9;Bcl2-
transgenic (Cas9;Bcl2-tg) mice were cultured on OP9-DLL1
stroma to initiate T cell development (see Materials and meth-
ods). After 2 d, beforemost had reached DN2 stage, the cells were
infected with retroviral vectors encoding single gRNA (sgRNA)
against Notch1, Notch2, and/or Notch3 together with CFP (here
used for mTurquoise2, a brighter version) or human nerve
growth factor receptor (hNGFR) reporters, and we analyzed the
sgRNA-transduced cells at 3 or 5 d postinfection (dpi; Fig. 1 B).
The targeted cell surface Notch proteins were specifically de-
pleted by 3 dpi (Fig. S1 A). As expected, deletion of Notch1, alone
or in combination, sharply reduced pro–T cell recovery (Fig. S1, B
and C). Deletion of Notch1 or Notch2 in phase 1 cells had minor
though reproducible effects on expression of one of the most
visible Notch targets, CD25, whereas Notch3 deletion had no
significant phenotypic effect. Notably, however, combined
Notch1 and Notch2 deletion downregulated CD25 profoundly
(especially at 5 dpi; Fig. 1, C and D; Fig. S1, D and E), a phenotype
much stronger than that with deletion of Notch1 alone. Also,
abundant cells expressing inappropriate lineage markers (Lin+)
were generated from Notch1 and Notch2 double-knockout (DKO)
cells (Fig. S1 F), more than whenNotch1 alone was deleted. Thus,
Notch1 alone does not account for all effects of Notch signaling
on phase 1 cells.
For Notch deletion in phase 2, precursors were cocultured
with OP9-DLL1 stroma for 10 d, when almost all of the cells had
transitioned through T lineage commitment to phase 2, before
they were transduced with sgRNA. Cells and RNA were again
analyzed at 3 or 5 dpi (Fig. 1 B and Fig. S1 A). In phase 2, CD25
expression was partially downregulated by deletion of Notch1,
but, again, stronger effects on CD25 expression were detected
when Notch2 was deleted together with Notch1 (Fig. 1, C and D;
and Fig. S1, D and E).
The implication that Notch1 collaborates with Notch2 in early
T lineage cells was unexpected. Among Notch ligands, DLL4 is
indispensable to support T cell development in vivo, and it
preferentially interacts with Notch1 rather than Notch2 (Hozumi,
2020). To test whether the OP9-DLL1 system could be exag-
gerating the potency of Notch2, we retested the effects of
Notch1 and/or Notch2 deletion using phase 1 cells cocultured on
OP9-DLL4 rather than on OP9-DLL1. As expected, disruption
of the Notch1 gene strongly reduced CD25 expression, whereas
Notch2 deletion alone now had no significant effect. Even so,
the combined loss of Notch1 and Notch2 (DKO) gave a markedly
harsher effect (Fig. 1, E and F; and Fig. S1 G), supporting sig-
naling via both Notch1 and Notch2.
To test whether different Notch family member deletions
affect the same or different target genes, Lin−CD45+ sgRNA-
infected cells in phase 1 or phase 2 were sorted for RNA se-
quencing (RNA-seq) analysis at 3 dpi (Fig. 1 B). Gene expression
impacts of the single and double KOs were related to normal
development by plotting expression levels of 65 indicator genes
against a fixed principal component (PC) analysis framework of
normal developmental stages (Zhou et al., 2019; see Materials
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and methods). The control phase 1 cells progressed to a state
similar to early, Bcl11b-nonexpressing DN2a cells. Single Notch1
or Notch2 KOs were only slightly retarded in development
(shifted rightward in PC1). In contrast, the patterns of gene
expression in Notch1 and Notch2 DKO phase 1 cells were closer to
reference DN1 cells (Fig. 2 A), even though they remained on the
T lineage trajectory, consistent with their Kit and CD25 ex-
pression profiles (compare Fig. 1 C, upper panels). Phase 2 con-
trol cells, as expected, had a gene expression pattern near
reference DN2b cells, whereas all the samples with Notch1 de-
letion (single or double KO) showed similarly delayed gene ex-
pression profiles, nearer to the Bcl11b+ DN2a cells (Zhou et al.,
2019; Fig. 2 A). These results generally support a specific con-
tributing role of Notch2, with Notch1, to T lineage progression in
phase 1.
Next, we defined differentially expressed genes (DEGs) af-
fected by Notch family member deletions, based on false
discovery rate <0.05, |log2 fold change| >1, and average reads per
kilobase million (RPKM) >1 across samples in phase 1 and phase
2 (Table S1 and Table S2). In this acute disruption system, despite
a strong effect of Notch1 deletion on cell recovery (Fig. S1 B), the
number of DEGs in the surviving Notch1 KO cells was small. In
contrast, the numbers of DEGs were much higher in Notch1 and
Notch2 DKO cells than in either Notch1 or Notch2 single KO cells
(Fig. 2 B). The responses of the DEGs defined inNotch1 andNotch2
DKO cells (“Notch-regulated DEGs”) to each Notch family per-
turbation are shown, for phase 1 and phase 2, in heat maps (Fig. 2
C). The contributions of Notch1 and Notch2 to the Notch-
regulated DEGs looked comparable in phase 1; the DKO caused
strong supra-additive effects and on most of the same genes as in
single KOs (Fig. 2 C, left). Notch3 played little role. However, in
phase 2, Notch1 seemed to be the main transducer of Notch
signals. There were only modestly increased effects on the target
genes if Notch2 or Notch3was disrupted together with Notch1 and
Figure 1. Notch1, Notch2, and Notch3 cooperatively control early T cell development. (A) RPKM values for Notch1, Notch2, Notch3, and Notch4 in DN
subsets (https://www.immgen.org; Yoshida et al., 2019). (B) Experimental scheme of work. (C) Representative c-Kit/CD25 profiles of sgRNA-transduced
Lin−CD45+CFP+hNGFR+ phases 1 and 2 cells. (D) Percentages of CD25+ cells among sgRNA-transduced cells (C), indicated with SD. (E) Representative c-Kit/
CD25 profiles in sgRNA-transduced cells cultured on OP9-DLL4. (F) The percentages of CD25+ cells in (E), indicated with SD. Results are representative of four
(C) or three (E) independent experiments or compiled from four (D) or three (F) independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; and ****, P <
0.0001 by one-way ANOVA followed by Dunnett’s test.
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Figure 2. Notch signaling regulates stage-specific target genes in pro-T cells. (A) PC analysis displays RNA-seq data from sgRNA-transduced phases 1 and
2 cells (see Materials and methods). White arrow represents the T cell developmental trajectory defined from reference standards (black symbols). (B) Number
of DEGs in Notch1-deficient (N1 KO), Notch2-deficient (N2 KO), Notch3-deficient (N3 KO), Notch1- and Notch2-deficient (N1+2 KO), and Notch1- and Notch3-
deficient (N1+3 KO) phase 1 or phase 2 cells. (C) Heat maps show expression changes of DEGs (B; N1+2 KO) in response to acute deletion of Notch genes as
indicated (Table S1 and Table S2). (D) Numbers of Notch-dependent (left) and Notch-repressed (right) DEGs in phases 1 and 2. (E and F) Representative RNA-
seq tracks for control and N1+2 KO cells at the Tcf7 (E) andMyc (F) loci. Data are based on two replicate samples of RNA-seq results (A–D) or are representative
of two replicate samples (E and F). FC, fold change; FDR, false discovery rate.
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little if any effects ifNotch2 orNotch3were deleted alone (Fig. 2 C,
right). Importantly, we also tested the responses of Notch-
regulated DEGs to Notch1 and/or Notch2 deletion in phase
1 cells cocultured with OP9-DLL4 to mimic the DLL4 in the
thymic microenvironment. These results supported those from
cells developing on OP9-DLL1, again showing significantly in-
creased intensities of response of the same genes in the
Notch1 and Notch2 DKO as compared with the Notch1 (or Notch2)
single KO samples (Fig. S2, A and B; and Table S3). Therefore,
Notch1 and Notch2 collaboratively regulate gene expression in
phase 1, whereas Notch1 mainly controls the Notch-regulated
DEGs in phase 2, in our experimental system.
This experimental system confirmed globally that the ma-
jority of Notch-regulated DEGs in phase 1 and phase 2 had stage-
specific responses (Fig. 2 D). It was previously known that
multiple genes that shared a dependence on Notch signaling,
such as Hes1, Nrarp, Dtx1, Il2ra (encoding CD25), Ptrca, and
Notch3, were expressed in different developmental patterns.
However, our results revealed that even important regulatory
genes that were strongly expressed at both stages showed stage-
dependent differential Notch control. Although Tcf7 was con-
firmed to be Notch activated as expected (Germar et al., 2011;
Weber et al., 2011), its Notch dependence was sharply confined
to phase 1 (Fig. 2 E). In contrast, proto-oncogeneMyc was Notch
dependent in phase 2 but not in phase 1 (Fig. 2 F). Other reported
Notch direct target genes, including Il2ra, Notch3, and Deptor,
had significant measurable Notch dependence in both phases
(“shared”). Notch signaling could repress some alternative lin-
eage genes in the thymus, both in phase 1 and in phase 2. Innate
lymphoid-related genes (Rora, Tox2, Id3, and Eomes) and
myeloid-related genes (Mpo, Rarg, Ly6c1, and Ccr2) were Notch
inhibited in both phases (“shared Notch repressed”; Table S1 and
Table S2). However, regulatory genes Cebpa, Cebpb, Cebpd, and
Cepbe, key for myeloid development, were only unleashed if
Notch was deleted in phase 1 (“phase 1–specific Notch repressed”;
Table S1 and Table S2). Gene Ontology (GO) analysis supported a
phase-dependent shift in Notch roles. In phase 1, genes involved
in “innate immune response” were enriched among “Notch-
repressed” genes, and “negative regulator of pro–B cell and
stem cell” categories were highly enriched among the phase
1 Notch-dependent genes (Fig. S2 C). In phase 2, instead, the
Notch signaling–dependent genes were enriched for genes re-
lated to T cell homeostasis, whereas “Notch-repressed” genes
were enriched for those encoding chemokine receptors and
positive regulators of transcription (Fig. S2 D).
The Notch-regulated DEGs include both direct and indirect
targets. We tested whether genomic regulatory sites bound by
complexes of Notch–ICN with its DNA binding partner, RBPJ,
were themselves changing between phase 1 and phase 2. RBPJ
binding and Notch1 ICN binding may occur independently but
most often coincide in mammalian systems (Castel et al., 2013),
especially for positive regulation. Because of antibody limi-
tations, T leukemias have been used for ICN and RBPJ chromatin
immunoprecipitation sequencing (ChIP-seq; Geimer Le Lay
et al., 2014; Herranz et al., 2014; Pinnell et al., 2015; Wang
et al., 2011; Yashiro-Ohtani et al., 2014) but not primary DN
pro-T cells. For RBPJ ChIP-seq analyses of primary phase 1 and
phase 2 cells (two replicates each), we used a mixture of two
mAbs with cross-linking conditions that preserve protein–
protein as well as protein–DNA interactions. The RBPJ ChIP-seq
results gave modest signal/noise ratios, limiting analysis, but
they confirmed normal use of many RBPJ sites previously found
in T cell acute lymphoblastic leukemia (T-ALL) cell lines (Pinnell
et al., 2015; Wang et al., 2011; Fig. S2, E–G). We scored 485 re-
producible RBPJ ChIP peaks in phase 1 and 4,000 in phase
2 (Fig. 3 A). The RBPJ motif was nicely enriched in these sites
from both phases (Fig. 3 B). The increased RBPJ binding in phase
2 was seen at many genes scored as phase 1 DEGs as well as at
phase 2 DEGs. However, stage-specific as well as shared peaks
were evident at correspondingly Notch-regulated target loci,
including Il2ra, Cebpa, Nrarp, and Notch3 (Fig. 3, C–F, stage-
specific sites boxed). The unexpected binding to a repression
target requires further study. Phase 2–specific binding was also
seen at the distal enhancer (Herranz et al., 2014; Yashiro-Ohtani
et al., 2014) of phase 2–specific target Myc (Fig. S2 H), whereas
weak but reproducible phase 1–specific binding was also found
at phase 1–expressed Deptor, Cd34, and Pdgfrb loci (not shown).
Conditional deletion of Notch1 or Dll4 in vivo leads to gener-
ation of B cells in the thymus (Hozumi et al., 2008; Radtke et al.,
1999). As noted above, we also observed many alternative line-
age marker–positive cells (“Lin+”) developing in vitro from
Notch1 and Notch2 DKO cells, especially when the Notch genes
were knocked out in phase 1 (Fig. S1 F). CD19+ B lineage cells
emerged at similar levels in all the cultures of Notch1-disrupted
cells. However, Notch2 loss substantially enhanced myeloid cell
production and showed an impact even when Notch1 was intact
(Fig. 4 A; Fig. S3 A). In these culture conditions, >70% of the
Notch1 and Notch2 DKO phase 1 cells expressed the myeloid
marker CD11b, whereas CD19+ B cells only made up ∼15% (Fig. 4
A; Mohtashami et al., 2010). Thus, Notch signaling, especially
through Notch2, either blocks outgrowth of myeloid cells or
blocks developmental diversion of pro-T cells to myeloid fates,
and Notch2 signals can mask myeloid potential when Notch1 is
disrupted alone.
To explore how Notch might block myeloid development,
we focused on transcription factor PU.1, which is naturally
expressed throughout phase 1 but can drive myeloid devel-
opment of pro-T cells if artificially elevated. Notch signaling
blocks this myeloid diversion, but the mechanism has not
been clearly demonstrated (Rothenberg et al., 2019; Ungerbäck
et al., 2018). PU.1 has natural proliferative roles in phase 1 pro-T
cells, but elevated PU.1 can inhibit the T cell program by several
mechanisms, including raising the threshold for effective Notch
signaling (Del Real and Rothenberg, 2013; Hosokawa et al., 2018;
Rothenberg et al., 2019). To test globally whether Notch oppo-
sition to PU.1 defines the identity of developing pro-T cells, we
compared genes defined as PU.1-regulated DEGs in phase 1 pro-T
cells (Hosokawa et al., 2018) with the phase 1 Notch-regulated
DEGs. Responses to PU.1 and responses to Notch together were
found to predict distinct associations with cell type. We identi-
fied 28 PU.1-repressed, Notch-dependent genes and 47 PU.1-
dependent, Notch-repressed genes (Fig. 4 B,magenta circles; Table
S4). The PU.1-repressed, Notch-dependent genes had a trend
toward high expression in DN subsets and γδ T cells among
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hematopoietic lineages (Fig. 4 C). In contrast, the PU.1-dependent
and Notch-repressed genes were selectively highly expressed in
myeloid lineages (Fig. 4 D); someweremarkers of distinctmyeloid
precursors naturally found in the thymus (Zhou et al., 2019). By
comparison, the 31 genes responding positively to both PU.1 and
Notch signaling in phase 1 cells showed an expression pattern
more biased to stem/multipotent progenitor or early pro-T cell
states (Fig. S3 B). Thus, genes divergently regulated by PU.1 and
Notch signaling within pro-T cells defined a split between early T
and myeloid lineage fates.
The developmental lineage associations of genes divergently
regulated by PU.1 and Notch were specific for this pair. The
relationships between Notch targets and targets of other factors
showed less of a global connection to developmental fate. For
example, Bcl11b is a prominent transcription factor after com-
mitment that occupies many open chromatin sites in phase 2, as
Figure 3. Stage-specific RBPJ binding around Notch target loci. (A) Overlap of reproducible RBPJ ChIP peaks scored in phases 1 and 2. (B) Top three
enriched sequence motifs from RBPJ ChIP peaks in phase 1 (left) and phase 2 (right). (C–F) Representative ChIP-seq and RNA-seq tracks around the Il2ra (C),
Cebpa (D), Nrarp (E), and Notch3 (F) loci are shown. Sites with stronger RBPJ binding signals in phase 1 or 2 are labeled with blue or magenta rectangles,
respectively. Data are based on ChIP-seq peaks scored as reproducible in two replicate samples (A and B).
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Figure 4. Notch signaling antagonizes PU.1
and prevents pro-T cells from adoptingmyeloid-
like fates. (A) Percentages of CD19+ (left) and
CD11b+ (right) cells among sgRNA-transduced
phase 1 cells (Fig. S1 F) are indicated with SD.
**, P < 0.01; ***, P < 0.001; and ****, P < 0.0001
by one-way ANOVA followed by Dunnett’s test.
Data are based on four independent experiments.
(B) Relationships between Notch-dependent,
Notch-repressed, PU.1-dependent, and PU.1-re-
pressed genes (Hosokawa et al., 2018) defined in
phase 1 cells (Table S4). Magenta circles indicate
groups of genes shown in C and D. (C and
D)Developmental patterns of expression of PU.1-
repressed and Notch-dependent genes (n = 28; C)
and PU.1-dependent and Notch-repressed genes
(n = 47; D; see Materials and methods).
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PU.1 does in phase 1 (Hu et al., 2018). When we compared Notch-
regulated DEGs and Bcl11b-regulated DEGs (Hosokawa et al.,
2018a) in phase 2 (Fig. S3 C and Table S4), Notch and Bcl11b
effects were more often concordant than divergent. However,
genes with different response patterns showed heterogeneous
expression patterns and did not clearly define any lineage sepa-
ration (Fig. S3, D and E). Thus, taken together, the results suggest
that Notch signaling activates T lineage genes and represses my-
eloid lineage genes simultaneously through antagonism of a large
subset of PU.1 functions during the PU.1-expressing phase 1 stage.
In this study, we show that Notch2 can act as a potent
transducer of Notch signaling that complements Notch1 signals
in phase 1 pro-T cells on OP9-DLL1 and OP9-DLL4 stromal cells
alike. This experimental system exposes quantitative kinetic
effects with high sensitivity by minimizing homeostatic com-
pensation. The effects of deleting Notch1 alone in this system
may seem surprisingly weak. Note that to initiate T lineage
differentiation in this acute deletion experimental system, the
cells first receive Notch signaling for the first 2 or 3 d, before
deletion of anyNotch genes. Thus, we cannot rule out an obligate
role for Notch1 at the earliest stage. However, it is interesting
that Notch2 has previously been reported to inhibit myeloid
differentiation specifically from Lin−Sca-1+Kit+ blood progeni-
tors (Varnum-Finney et al., 2011). New evidence has increased
the likelihood that prethymic Notch signaling, which might in-
clude a role for Notch2, is relevant to enabling T cell develop-
ment at all (Chen et al., 2019). Studies using a mouse strain in
which RBPJ could be deleted and then inducibly restored yielded
strong evidence that Notch signaling via RBPJ needs to be acti-
vated in BM-resident multipotent progenitors even before they
reach the thymus (Chen et al., 2019). Multipotent progenitors
express less Notch1 relative to Notch2 than lymphoid-biased
precursors such as Common Lymphoid Progenitors (CLP) and
ETP (Kit+ DN1 pro-T cells; Yoshida et al., 2019), and our results
suggest that Notch2 is important to restrain myeloid differen-
tiation of the phase 1 cells. Hence, although T cell differentiation
ismost strongly promoted byNotch1–DLL4 interaction, different
developmental alternatives may be excluded by complementary
actions of Notch1 and Notch2.
The findings in this reductionist system indicate a broader
repertoire of functional signaling receptiveness of the pro-T
cells but do not contradict the evidence that Notch1–DLL4 in-
teraction is sufficient and indispensable to support normal T cell
development in vivo. An important question is why Notch2 and
Notch3 cannot compensate for the effect of Notch1 deletion on
T cell development in vivo. Part of the answer is likely to be
quantitative because neither one is regulated in a way that
sustains activity across the phase 1–phase 2 transition. However,
certain gatekeeper events in the thymus in vivo could also be
exquisitely dependent on high-affinity Notch1–DLL4 interac-
tions. In fact, a specific niche of vascular endothelial cells with
DLL4 and membrane-bound Kit ligand (stem cell factor) ex-
pression has been described as the initial entry domain for ETP
(Kithi DN1) cells in the thymus (Buono et al., 2016).
An obstacle to complementation analysis has been the grave
impact of deleting Notch genes on multiple developmental de-
cisions in vivo. Here, using an efficient, acute deletion system
with real-time longitudinal monitoring, we show that Notch
family genes work synergistically to drive the earliest T cell
development. Notch signaling not only activates T lineage sig-
nature genes but also represses adoption of alternative fates,
particularly in phase 1 while those alternatives are still open.
Therefore, Notch1 and Notch2 enable T cell development by
activation and repression of gene expression, directly and
indirectly.
Materials and methods
Mice
C57BL/6 (referred to as “B6”), B6.Cg-Tg(BCL2)25Wehi/J (Bcl2-tg;
Strasser et al., 1991), and B6.Gt(ROSA)26Sortm1.1(CAG-cas9*,-EGFP)Fezh/J
(Cas9; Platt et al., 2014) mice were purchased from The Jackson
Laboratory. These were crossed to generate B6-Cas9/+;+/Bcl2 het-
erozygotes for each experiment. All animals were bred and main-
tained in the California Institute of Technology Laboratory Animal
Facility under specific pathogen–free conditions, and the protocol
supporting animal breeding for this work was reviewed and ap-
proved by the institutional animal care and use committee of the
California Institute of Technology. The Bcl2 transgene was routinely
incorporated into the genetic background because it enhances sur-
vival (and thus intact RNA recovery) from pro-T cells with regula-
tory perturbations, without altering pro–T cell development in the
control animals (Franco et al., 2006; Taghon et al., 2007; Yui et al.,
2010).
Cell culture
For in vitro differentiation of pro-T cells, BM hematopoietic
progenitors were used for input. BM was removed from the
femurs and tibiae of 2–3-mo-old mice. Suspensions of BM cells
were prepared and stained for lineage markers using biotin-
conjugated lineage antibodies (CD11b, CD11c, Gr1, TER-119,
NK1.1, CD19, CD3ε), then incubated with streptavidin-coated
magnetic beads (Miltenyi Biotec) and passed through a mag-
netic column (Miltenyi Biotec). Then, hematopoietic progeni-
tors were cultured on OP9-DLL1 or OP9-DLL4 monolayers using
OP9 medium (α-MEM, 20% FBS, 50 µM β-mercaptoethanol,
Pen-Strep-Glutamine) supplemented with 10 ng/ml of IL-7
(PeproTech Inc.) and 10 ng/ml of Flt3L (PeproTech Inc). On day
7, cultured cells were disaggregated, filtered through 40-µm
nylon mesh, and recultured on new OP9 monolayers with
medium containing 5 ng/ml of IL-7 and 5 ng/ml of Flt3L. In
cultures that were continued for longer times, cells were pas-
saged onto fresh OP9-DLL1 monolayers at day 10 and main-
tained up to day 15 in 1 ng/ml each of IL-7 and Flt3L.
CRISPR/Cas9-mediated acute deletion of Notch in T cell
development cultures
To generate input cells, Cas9mice were first bred to Bcl2-tg mice
to generate heterozygotes for both transgenes. BM cells from
these Cas9;Bcl2-tg animals were then used to seed in vitro dif-
ferentiation cultures as above. At day 2 (phase 1) or 10 (phase 2),
the cells were transduced with retroviral vectors encoding re-
porters (CFP and hNGFR) and the indicated sgRNAs as detailed
below and then returned to OP9-DLL1 culture. Themethods used
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to generate the virus supernatant and for infection were
described previously (Hosokawa et al., 2018a). Cells were
analyzed after another 3 or 5 d of culture. For RNA-seq,
retrovirus-infected Lin−CD45+c-KithiCFP+hNGFR+ (phase 1) or
Lin−CD45+c-KitloCFP+hNGFR+ (phase 2) cells were sorted on a
BD FACSAria FACS.
Cloning
The sgRNA expression vector (E42-dTet) we used was described
previously (Hosokawa et al., 2018). 19-mer sgRNAs were de-
signed using the CHOPCHOP web tool (https://chopchop.cbu.
uib.no/) and inserted into the empty sgRNA expression vector
by PCR-based insertion. Three sgRNA expression vectors were
generated for one gene, and pooled retroviral plasmids were
used tomake retroviral supernatant. Sequences of sgRNAs used in
this study are as follows: control (luciferase): ggcatttcgcagcctaccg;
Notch1 no. 1: ctggcgagcaggcatgcca; Notch1 no. 2: tggggccatggaagc
cagg; Notch1 no. 3: tacctcttgcggcgagcgc; Notch2 no. 1: ccaacgcttgtc
agaatgg; Notch2 no. 2: ctttccccaacatgccctg; Notch2 no. 3: agtaccacc
attctgacag; Notch3 no. 1: ggccatcaggcgacgacgg; Notch3 no. 2: tgggct
tccatccagacaa; and Notch3 no. 3: caacgacaggagaatcggg.
Flow cytometric analysis
For cell-surface staining of sgRNA-introduced BM cells, anti-
bodies against Notch1, conjugated to phycoerythrin (Notch1 PE;
catalog no. 130607; BioLegend), Notch2 PE (catalog no. 130707),
Notch3 PE (catalog no. 130507), CD45 PE-cyanine 7 (catalog no.
25-0451-82; eBioscience), c-Kit allophycocyanin (catalog no. 17-
1171-82), CD25 allophycocyanin-e780 (catalog no. 47-0251-82),
human-NGFR PE (catalog no. 12-9400-42), and a biotin-
conjugated lineage cocktail [CD8α (catalog no. 13-0081-86),
CD11b (catalog no. 13-0112-86), CD11c (catalog no. 13-0114-
85), Gr-1 (catalog no. 13-5931-86), TER-119 (catalog no. 13-5921-85),
NK1.1 (catalog no. 13-5941-85), CD19 (catalog no. 13-0193-85), TCRβ
(catalog no. 13-5961-85), and TCRγδ (catalog no. 13-5711-85)] were
used for staining. Prior to cell surface staining, cells were treated
with 2.4G2 cell supernatant. All of the cells were analyzed using
a flow cytometer, MACSQuant 10 (Miltenyi Biotec), FACSAria
Fusion (BD Biosciences), or LSRFortessa (BD Biosciences), with
FlowJo software (FlowJo LLC).
ChIP and ChIP-seq
5–10 × 106 cells were fixed with 1 mg/ml DSG (Thermo Fisher
Scientific) in PBS for 30 min at RT followed by an additional
10minwith addition of formaldehyde up to 1%. The reactionwas
quenched by addition of a 1:10 volume of 0.125 M glycine, and
the cells were washed with Gibco HBSS (Thermo Fisher Scien-
tific). Pelleted nuclei were dissolved in lysis buffer (0.5% SDS,
10 mM EDTA, 0.5 mM EGTA, 50 mM Tris-HCl [pH 8] and
Protease Inhibitor Cocktail [Roche #11873580001]) and soni-
cated on a Bioruptor (Diagenode) for 18 cycles of 30-s sonication
followed by 30-s rest, with maximum power. Five micrograms
of anti-RBPJ mAbs (a mixture of 2.5 µg of 5313 [Cell Signaling
Technology] and 2.5 µg of ab180588 [Abcam]) were prebound to
Dynabeads antirabbit Ig (Invitrogen) and then added to the di-
luted chromatin complexes in parallel aliquots. The samples
were incubated overnight at 4°C, then washed and eluted for 6 h
at 65°C in ChIP elution buffer (20 mM Tris-HCl, pH 7.5, 5 mM
EDTA, 50 mM NaCl, 1% SDS, and 50 µg/ml proteinase K). Pre-
cipitated chromatin fragments were cleaned up using ChIP DNA
Clean & Concentrator (Zymo Research). ChIP-seq libraries were
constructed using the NEBNext ChIP-Seq Library Preparation
Kit (catalog no. E6240; New England Biolabs) and sequenced on
an Illumina HiSeq 2500 system in single-read mode with a read
length of 50 nt. Analysis pipelines used are described below
under the “ChIP-seq analysis” and “RNA-seq analysis” subhead-
ings. All analyses are based on results from at least two biologically
separate replicates.
mRNA preparation and RNA-seq
Total RNA was isolated from samples of 1–2 × 105 cultured cells
using the RNeasyMicro Kit (Qiagen). Libraries were constructed
using the NEBNext Ultra RNA Library Prep Kit for Illumina
(catalog no. E7530; New England Biolabs) from ∼1 µg of total
RNA following the manufacturer’s instructions. Libraries were
sequenced on the Illumina HiSeq 2500 system in single-read
mode with a read length of 50 nt. Base calls were performed
with RTA 1.13.48.0 followed by conversion to FASTQ with
bcl2fastq 1.8.4 and produced ∼30 million reads per sample.
ChIP-seq analysis
Base calls were performed with RTA 1.13.48.0 followed by con-
version to FASTQ with bcl2fastq 1.8.4 and produced ∼30 million
reads per sample. ChIP-seq data were mapped to the mouse
genome build NCBI37/mm10 using Bowtie (version 1.1.1; http://
bowtie-bio.sourceforge.net/index.shtml) with “-v 3 -k 11 -m
10 -t--best --strata” settings, and HOMER tag directories were
created with makeTagDirectory and visualized in the UCSC Ge-
nome Browser (http://genome.ucsc.edu; Speir et al., 2016). ChIP
peaks were identified with findPeaks.pl against a matched control
sample using the settings “-P .1 -LP .1 -poisson .1 -style factor.” The
identified peaks were annotated to genes with the annotate-
Peaks.pl command against the mm10 genomic build in the
HOMER package. Peak calls were always based on data from at
least two independent biological replicates. Peak reproduci-
bility was determined by a HOMER adaptation of the IDR (Ir-
reproducibility Discovery Rate) package according to ENCODE
guidelines (https://sites.google.com/site/anshulkundaje/projects/
idr). Only reproducible high-quality peaks, with a normalized
peak score ≥15, were considered for further analysis. Motif
enrichment analysis was performed with the findMotifsGeno-
me.pl command in the HOMER package using a 200-bp win-
dow. Notch IC and RBPJ ChIP-seq data in a T-ALL cell line, 8946,
used in this study were previously published (GEO accession
no. GSE66147; Pinnell et al., 2015).
RNA-seq analysis
RNA-seq reads were mapped onto the mouse genome build
NCBI37/mm10 with STAR (version 2.4.0; Dobin et al., 2013) and
post-processed with RSEM (version 1.2.25; http://deweylab.
github.io/RSEM/; Li and Dewey, 2011) according to the set-
tings in the ENCODE long-rna-seq-pipeline (https://github.com/
ENCODE-DCC/long-rna-seq-pipeline/blob/master/DAC/STAR_
RSEM.sh) with the minor modifications that settings “--output-
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genome-bam --sampling-for-bam” was added to rsem-calculate-
expression. STAR and RSEM reference libraries were created
from genome build NCBI37/mm10 together with the Ensembl
genemodel fileMus_musculus.NCBIM37.66.gtf. The resulting bam-
files were used to create HOMER (Heinz et al., 2010) tag directories
(makeTagDirectory with -keepAll setting). For analysis of statistical
significance among DEGs, the raw gene counts were derived from
each tag directory with analyzeRepeats.pl with the -noadj -con-
denseGenes options followed by the getDiffExpression.pl command
using EdgeR (version 3.6.8; http://bioconductor.org/packages/
release/bioc/html/edgeR.html; Robinson et al., 2010). For data
visualization, RPKM normalized reads were derived using the
analyzeRepeats.pl command with the options -count exons
-condenseGenes -rpkm followed by log transformation. The
normalized datasets were hierarchically clustered with
“average” linkage and visualized in MATLAB (clustergram).
GO analysis was performed using the DAVID analysis tool
(https://david.ncifcrf.gov).
UCSC Genome Browser Bigwig visualization
BigWigs were generated from the aligned SAM or BED file for-
mats using Samtools (Hosoya et al., 2009), Bedtools (Quinlan
and Hall, 2010), and the UCSC genomeCoverageBed and bed-
GraphToBigWig and normalized to 1 million reads. For visuali-
zation of RNA-seq tracks, bamToBed and genomeCoverageBed
were used with the “-split” setting enabled. BigWig files were
uploaded to the UCSC Genome Browser (http://genome.ucsc.
edu; Speir et al., 2016) for visualization.
PC analysis
PC loading for 65 curated T cell developmental trajectory genes
was obtained from a previous single-cell RNA-seq study (Zhou
et al., 2019). After the PC analysis of single-cell RNA-seq, the PC
loadings of PCs 1 and 2 were projected to bulk RNA-seq data.
Reference bulk RNA-seq results for in vivo thymocytes (DN1,
DN2a, DN2b, and DN3)were reported previously (GEO accession
no. GSE130812 and GEO accession no. GSE115744; Hosokawa
et al., 2018a; Zhou et al., 2019). PC analysis displays RNA-seq
data from sgRNA-transduced Lin−CD45+CFP+hNGFR+ phase 1
and phase 2 cells at 3 dpi. In the plot, colored circles represent
phase 1 samples, and colored hexagons represent phase 2 sam-
ples. Black symbols indicate the reference unperturbed DN
subsets from previous studies (Hosokawa et al., 2018a; Zhou
et al., 2019). A curved arrow represents the T cell develop-
mental trajectory defined in controls.
Analysis of developmental expression patterns of
selected genes
Expression is characterized among multilineage precursors and
hematopoietic cells, including B cells, dendritic cells, macro-
phages, monocytes, granulocytes, DN cells (thymocytes), mature
αβ T cells, natural killer (NK) T cells, γδ T cells, and NK cells. The
heat map display is taken from the Immunological Genome web
site (http://www.immgen.org/; Heng et al., 2008; Mingueneau
et al., 2013; Yoshida et al., 2019) using the MyGeneSet tool and
ImmGen ULI RNA-seq. Color scale indicates z scores, with warm
colors indicating higher relative levels and cold colors indicating
lower relative levels. Venn diagrams were generated using the
Bioinformatics & Evolutionary Genomics webtool (http://
bioinformatics.psb.ugent.be/webtools/Venn/). PU.1-regulated
and Bcl11b-regulated DEGs were reported previously and were
defined in primary pro-T cells by concordant (opposite) responses
in gain and loss of PU.1 function (Table S6 B in Ungerbäck et al.,
2018) or by concordant responses to Cas9 and Cre-mediated de-
letion for Bcl11b (Hosokawa et al., 2018a; Table S3). The same PU.1
and Bcl11b target gene lists and their statistical cutoffs were de-
scribed previously (Zhou et al., 2019).
Statistical analysis
DEGs were defined using EdgeR, typically with false discovery
rate <0.05, |log2 fold change| >1, and RPKM >1, except when
otherwise indicated, on the basis of measurements from at least
two biologically independent replicates for each sample type.
The statistical significance of differences between datasets was
determined by one-way ANOVA, followed by Dunnett’s multiple
comparisons test using Prism 8 software (GraphPad Software).
Statistical details of experiments can be found in the figure
legends. In all figures, error bars indicate SD.
Data availability
The accession number for all the new deep-sequencing data
reported in this paper is GEO accession no. GSE148441.
Online supplemental material
Fig. S1 shows conformation of the KO of Notch family molecules
by flow cytometry, cell recovery of Notch KO cells, and CD25 and
non–T lineage marker expression profiles. Fig. S2 shows heat
maps for gene expression changes in response to Notch family
KO in pro-T cells cultured on OP9-DLL4, results of GO analysis
for Notch-regulated DEGs, and comparison of RBPJ ChIP-seq
results with previously published RBPJ ChIP-seq data in T-ALL
cell lines. Fig. S3 shows cell numbers of CD19+ and CD11b+ cells in
Notch KO phase 1 cells and the relationship between Bcl11b-
regulated DEGs and Notch-regulated DEGs in phase 2. Table S1
lists the Notch-regulated DEGs in phase 1. Table S2 shows the list
of Notch-regulated DEGs in phase 2. Table S3 lists the Notch-
regulated DEGs in phase 1 cells cocultured on OP9-DLL4. Table
S4 shows the genes regulated in different patterns by Notch
signaling, PU.1, and Bcl11b for Fig. 4 B and Fig. S3 C.
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Figure S1. Acute deletion of Notch accelerates generation of Lin+ cells. (A) Flow cytometric analysis of phase 1 (upper) and phase 2 (lower) pro-T cells was
performed at 3 dpi. Representative Notch1, Notch2, and Notch3 profiles in Lin−CD45+CFP+ sgRNA-transduced cells are shown. Results are representative of
two independent experiments. (B and C) Flow cytometric analysis of phase 1 and phase 2 DN cells was performed at 3 dpi (B) or 5 dpi (C). Relative cell numbers
of Lin−CD45+CFP+hNGFR+ sgRNA-transduced cells against sgControl-transduced cells are shown with SD. Data are based on three independent experiments.
(D) Flow cytometric analysis of phase 1 (upper) and phase 2 (lower) DN cells was performed at 3 dpi. Representative c-Kit/CD25 profiles in Lin−CD45+CFP+hNGFR+
sgRNA-transduced cells are shown. Results are representative of four independent experiments. (E) The percentages of CD25+ cells among Lin−CD45+CFP+hNGFR+
sgRNA-transduced phase 1 and phase 2 cells at 3 dpi (D) are indicated with SD. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by one-way ANOVA followed by
Dunnett’s test. Data are based on four independent experiments. (F) Flow cytometric analysis of phase 1 pro-T cells (Fig. 1 C) was performed at 5 dpi. Representative
Lin profiles in CD45+CFP+hNGFR+ sgRNA-transduced cells are shown. Numbers indicate percentages of Lin– cells. Results are representative of four independent
experiments. (G) Flow cytometric analysis of phase 1 pro-T cells, cocultured on OP9-DLL4, was performed at 3 dpi. Relative cell numbers of Lin−CD45+CFP+hNGFR+
sgRNA-transduced cells against sgControl-transduced cells are shown with SD. Data are based on three independent experiments.
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Figure S2. Phase 1 cells on OP9-DLL1 and OP9-DLL4 have similar gene expression changes in response to deletion of Notch1 and Notch2. (A) Heat
maps show hierarchical clustering of expression change in response to acute deletion of Notch1 and Notch2 (Notch-dependent genes, left, and Notch-repressed
genes, right) in phase 1 cells cultured on OP9-DLL1 (Fig. 2 C, left), with phase 1 cells cultured on DLL4 (Fig. 1 E). (B)Number of DEGs inNotch1-deficient (N1 KO),
Notch2-deficient (N2 KO), and Notch1- and Notch2-deficient (N1+2 KO) phase 1 cells cultured on OP9-DLL4 are shown. (C and D) GO annotation was performed
using the DAVID analysis tool (https://david.ncifcrf.gov/). Top five GO terms for Notch-dependent (top) and Notch-repressed (bottom) target genes are shown
in phase 1 (C) and phase 2 (D). (E) The top three enriched sequencemotifs of RBPJ ChIP peaks in previously reported RBPJ ChIP peaks in a T-ALL cell line (Pinnell
et al., 2015) are shown. (F) Venn diagrams show the numbers of reproducible RBPJ ChIP peaks in phase 2 in this study and previously reported RBPJ ChIP peaks
in a T-ALL cell line. (G) ChIP-seq tracks for ICN1 and RBPJ in T-ALL cell lines (Pinnell et al., 2015; Wang et al., 2011) and RBPJ in phase 2 pro-T cells are compared
around the Il2ra and Notch3 loci. (H) Representative ChIP-seq tracks for RBPJ around the Myc enhancer region are shown. The site with stronger RBPJ binding
signals in phase 2 is labeled with a magenta rectangle.
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Figure S3. Relationship between Notch-regulated DEGs and Bcl11b-regulated DEGs. (A) Relative cell numbers of CD19+ (left) or CD11b+ (right) in
CD45+CFP+hNGFR+ sgRNA-transduced cells against sgControl-transduced phase 1 cells at 5 dpi are shown with SD. Data are based on three independent
experiments. (B) The heat map shows developmental patterns of expression of PU.1-dependent and Notch-dependent genes (n = 31; green circle in Fig. 4 B)
among multilineage precursors and other hematopoietic cells, including B cells, dendritic cells, macrophages, monocytes, granulocytes, DN cells (thymocytes),
mature αβ T cells, NKT cells, γδ T cells, and NK cells. The heat map is taken from the Immunological Genome web site (http://www.immgen.org/; Heng et al.,
2008; Mingueneau et al., 2013; Yoshida et al., 2019) using the MyGeneSet tool and ImmGen ULI RNA-seq. Color scale indicates z scores, with warm colors
indicating higher relative levels and cold colors indicating lower relative levels. (C) Venn diagrams show the number of Notch-dependent, Notch-repressed,
Bcl11b-dependent, and Bcl11b-repressed genes (Hosokawa et al., 2018a) in phase 2 DN cells. Magenta circles indicate groups of genes characterized further in
D and E. Data are based on two replicate samples of RNA-seq results. (D and E) The heat maps show developmental patterns of expression of Bcl11b-
dependent and Notch-dependent genes (n = 9; D) and Bcl11b-repressed and Notch-repressed genes (n = 24; E) from gene groups in magenta circles in C.
Expression is compared among multilineage precursors and hematopoietic cells as in B.
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Provided online are four tables. Table S1 lists the Notch-regulated DEGs in phase 1. Table S2 lists the Notch-regulated DEGs in phase 2.
Table S3 lists the Notch-regulated DEGs in phase 1 cells cocultured on OP9-DLL4. Table S4 shows the genes regulated in different
patterns by Notch signaling, PU.1, and Bcl11b.
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